2-Day Alzheimer’s Disease and Other Neurocognitive Disorders Conference: Update on Risks, Treatment and Evidence-Based Management of Complex Issues- M. Catherine Wollman

Total Size:Digital products: Get the download link at Account or directly via email.Support: LifetimeDownload: Unlimited Of Course 2-Day Alzheimer’s Disease and Other Neurocognitive Disorders Conference: Update on Risks, Treatment and Evidence-Based Management of Complex Issues- M. Catherine WollmanPurchase 2-Day Alzheimer’s Disease and Other Neurocognitive Disorders Conference: Update on Risks, Treatment and Evidence-Based Management of Complex Issues- M. Catherine Wollman courses at here with PRICE $439.99 $180When purchasing 2-Day Alzheimer’s Disease and Other Neurocognitive Disorders Conference: Update on Risks, Treatment and Evidence-Based Management of Complex Issues- M. Catherine Wollman course, You can get it with the LIFETIME SUPPORT and UNLIMITED DOWNLOAD.2-Day Alzheimer’s Disease and Other Neurocognitive Disorders Conference: Update on Risks, Treatment and Evidence-Based Management of Complex Issues- M. Catherine WollmanAlzheimer’s disease and other neurocognitive disorders are disabling health conditions that create daunting challenges to patients, families and clinicians.Are you prepared to manage and anticipate the complex patient needs that emerge when caring for these patients?Have there been times in the past that you wished you had done more…?Catherine Wollman, DNP, CRNP, GNP-BC, will provide the very latest research about who’s at risk, what’s at stake, and what we can realistically do to manage the impact of neurocognitive disorders.Knowledge and evidence in dementia care are constantly changing. We will focus on the newest science, but also the use of ingenuity and compassion to address the multiple problems facing patients and families.Unique clinical challenges will be reviewed using personal stories and case studies to decide the best pharmacological and non-pharmacological interventions to transform your own practice.Alzheimer’s disease and other neurocognitive disorders will touch almost all of us personally or professionally.During this intense recording, Catherine will provide you with new clinical insights and critical thinking skills so that you won’t need to feel uncertain, frustrated or at risk anymore!Differentiate cognitive impairment, dementias, neurocognitive disorders and their unique symptoms and trajectories.Review new DSM5™ changes and updated research on neurocognitive disorders.Evaluate the current status of dementia research, including new risks, causes and prevention of Alzheimer’s disease.Summarize screening tools and diagnostic methods for neurocognitive disorders.Recognize the impact of neurocognitive disorders/ dementias on the individual, family, caregivers and healthcare providers.Develop a comprehensive interdisciplinary plan of care for the patient and family with neurocognitive disorders/ dementias.Synthesize evidence-based interventions for behavioral and psychological symptoms of dementia.Discuss pharmacologic therapy for neurocognitive disorders/ dementias, delirium and depression.Summarize clinical updates on delirium from prevention and early recognition to effective management.Examine ethical issues related to neurocognitive disorders including capacity, safety, diagnosis disclosure, palliative and end of life care.Improve quality of life and outcomes of care for patients and families with neurocognitive disorders/ dementias.Analyze case studies of complex patients with neurocognitive disorders/ dementias.Neurocognitive Disorders, Dementia and Cognitive ImpairmentDSM-5™ changes and terminologyAging and neurodegenerationNew research related to pathophysiology, diagnosis, risk factors and preventionDifferentiate Neurodegenerative DisordersAlzheimer’s diseaseVascular diseaseFrontotemporal disorderLewy body diseaseTraumatic Brain InjuryUpdate on DeliriumAcute or persistent deliriumScreening and diagnosisPrevent life threatening consequencesEvidence-based medications and treatmentLong term consequencesDiagnosis of Neurocognitive Disorders/DementiasReversible dementia-like disorders and conditionsValidated cognitive screening toolsNew diagnostic criteria and stages of dementiaFamily response to diagnosisPharmacologic Therapies for Neurocognitive Disorders/DementiasCholinesterase inhibitorsNMDA receptor antagonistsAntidepressantsAntipsychotics and other psychotropic drugsEvaluate new drugs and learn medications to avoidConsider risk, side effects, and efficacy for older adultsBehavioral and Psychological Symptoms of Dementia (BPSD)Vast majority of patients with one or more BPSDSerious negative consequences of untreated behaviorsTools to systematically assess the presence and severity of symptomsInvestigation of multiple contributing factorsInterdisciplinary creation and evaluation of a treatment planInterventions for Common Distressing BehaviorsAgitation, anxiety and restlessness that lead to emotional distress and disabilityApathy that contributes to poor prognosis and increased mortalitySexually inappropriate behaviors – one of the most distressing behaviorsFrustration of changing behaviors over timeBest Practice for Unique ChallengesEliminate pain-inducing factors to diminish behaviorsNutrition and hydration challenges with disease progressionSleep disorders and evidencebased managementDepression and effective therapyPsychotic symptoms: Nonpharmacological and pharmacological interventionsEthical IssuesSafety, function and autonomyComfort and dignityAdvance care planningPalliative care and hospiceGenetic testingDisclosure of diagnosisPatient/Family Needs Across the Disease TrajectoryProfessional and family caregiversCommunity ResourcesCase Studies and Clinical StoriesAre you interested in? neurocognitive disorders list; neurocognitive disorder unspecified; neurocognitive disorders; neurocognitive academy; neurocognitive domainsPurchasing 2-Day Alzheimer’s Disease and Other Neurocognitive Disorders Conference: Update on Risks, Treatment and Evidence-Based Management of Complex Issues- M. Catherine Wollman course now, You can get it with the LIFETIME SUPPORT and UNLIMITED DOWNLOAD.Purchase 2-Day Alzheimer’s Disease and Other Neurocognitive Disorders Conference: Update on Risks, Treatment and Evidence-Based Management of Complex Issues- M. Catherine Wollman courses at here with PRICE $439.99 $180